Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Goodwill & Intangibles (2022 - 2026)

Catalyst Pharmaceuticals filings provide 5 years of Goodwill & Intangibles readings, the most recent being $122.0 million for Q1 2026.

  • On a quarterly basis, Goodwill & Intangibles fell 46.44% to $122.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $122.0 million, a 46.44% decrease, with the full-year FY2025 number at $131.7 million, down 42.18% from a year prior.
  • Goodwill & Intangibles hit $122.0 million in Q1 2026 for Catalyst Pharmaceuticals, down from $131.7 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $227.7 million in Q2 2024 to a low of $32.5 million in Q4 2022.
  • Median Goodwill & Intangibles over the past 5 years was $184.1 million (2023), compared with a mean of $166.1 million.
  • Biggest five-year swings in Goodwill & Intangibles: soared 497.61% in 2023 and later tumbled 46.44% in 2026.
  • Catalyst Pharmaceuticals' Goodwill & Intangibles stood at $32.5 million in 2022, then soared by 497.61% to $194.0 million in 2023, then increased by 17.35% to $227.7 million in 2024, then plummeted by 42.18% to $131.7 million in 2025, then decreased by 7.37% to $122.0 million in 2026.
  • The last three reported values for Goodwill & Intangibles were $122.0 million (Q1 2026), $131.7 million (Q4 2025), and $128.6 million (Q3 2025) per Business Quant data.